Group One Trading
LOGC

Group One Trading’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Group One Trading’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,200
Closed – – 8473
2022
Q3 		$0 Hold
1,200
– – ﹤0.01% 8581
2022
Q2 		$0 Buy
1,200
+100
+9% +$51 ﹤0.01% 8844
2022
Q1 		$1K Hold
1,100
– – ﹤0.01% 7922
2021
Q4 		$3K Buy
+1,100
New +$3.72K ﹤0.01% 7841

Group One Trading's LOGC Position: Q4 2022 in Review

Group One Trading sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q4 2022, closing a stake of 1,200 shares.

Group One Trading first reported a position in LOGC in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold LOGC as of Q4 2022.

  • Group One Trading reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 1,200 LogicBio Therapeutics, Inc. Common Stock shares in Q4 2022.
  • Group One Trading first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Group One Trading's LogicBio Therapeutics, Inc. Common Stock position peaked at $3K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.